Dual inhibition of EGR1/STAT3 transcriptional hubs suppresses macrophage-driven liver fibrosis: A multi-omics-guided drug repurposing strategy
- 5 July 2025
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 240, 117120
Abstract
No abstract availableKeywords
Funding Information
- Xinjiang Medical University (2022A03007-4)
This publication has 40 references indexed in Scilit:
- Vitamin D receptor attenuates carbon tetrachloride-induced liver fibrosis via downregulation of YAPJournal of Hazardous Materials, 2024
- A Descriptor Set for Quantitative Structure‐property Relationship Prediction in BiologicsMolecular Informatics, 2022
- PDB‐101: Educational resources supporting molecular explorations through biology and medicineProtein Science, 2021
- Single‐Cell Transcriptomic Analysis Reveals a Hepatic Stellate Cell–Activation Roadmap and Myofibroblast Origin During Liver Fibrosis in MiceHepatology, 2021
- Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLDHepatology, 2020
- Nonalcoholic Fatty Liver Disease and Obesity TreatmentCurrent Obesity Reports, 2019
- Macrophages in Tissue Repair, Regeneration, and FibrosisImmunity, 2016
- Kupffer Cells in the LiverComprehensive Physiology, 2013
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Pioglitazone attenuates diet-induced hypertension in ratsMetabolism, 1995